MLchartDataset catalogue

autologous anti-FcRL5 CAR-T cells

Term · Oncology and biomedicine · MLC-T-ONC-011427

A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting Fc receptor-like protein 5 (FcRL5; Fc receptor-homolog 5; FcRH5), with potential antineoplastic activity. Upon administration, autologous anti-FcRL5 CAR-T cells recognize and kill FcRL5-expressing tumor cells. FcRL5, an immune receptor translocation-associated protein/Fc receptor homolog (IRTA/FcRH) family member and a B-cell lineage marker, is overexpressed in multiple myeloma.

Table 1. Record
IdentifierMLC-T-ONC-011427
FieldOncology and biomedicine
Synonymsanti-FcRL5 CAR-modified T cells; autologous anti-FcRL5 CAR T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011427",
  "term": "autologous anti-FcRL5 CAR-T cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting Fc receptor-like protein 5 (FcRL5; Fc receptor-homolog 5; FcRH5), with potential antineoplastic activity. Upon administration, autologous anti-FcRL5 CAR-T cells recognize and kill FcRL5-expressing tumor cells. FcRL5, an immune receptor translocation-associated protein/Fc receptor homolog (IRTA/FcRH) family member and a B-cell lineage marker, is overexpressed in multiple myeloma.",
  "synonyms": [
    "anti-FcRL5 CAR-modified T cells",
    "autologous anti-FcRL5 CAR T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-fcrl5-car-t-cells/"
}

Record 2,759 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.